Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

被引:841
作者
Yamamoto, A [1 ]
Lucas, JJ [1 ]
Hen, R [1 ]
机构
[1] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA
关键词
D O I
10.1016/S0092-8674(00)80623-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative disorders like Huntington's disease (HD) are characterized by progressive and putative irreversible clinical and neuropathological symptoms, including neuronal protein aggregates. Conditional transgenic models of neurodegenerative diseases therefore could be a powerful means to explore the relationship between mutant protein expression and progression of the disease. We have created a conditional model of HD by using the tet-regulatable system. Mice expressing a mutated huntingtin fragment demonstrate neuronal inclusions, characteristic neuropathology, and progressive motor dysfunction. Blockade of expression in symptomatic mice leads to a disappearance of inclusions and an amelioration of the behavioral phenotype. We thus demonstrate that a continuous influx of the mutant protein is required to maintain inclusions and symptoms, raising the possibility that HD may be reversible.
引用
收藏
页码:57 / 66
页数:10
相关论文
共 54 条
  • [21] Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
    Hansson, O
    Petersén, Å
    Leist, M
    Nicotera, P
    Castilho, RF
    Brundin, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) : 8727 - 8732
  • [22] EARLY LOSS OF NEOSTRIATAL STRIOSOME NEURONS IN HUNTINGTONS-DISEASE
    HEDREEN, JC
    FOLSTEIN, SE
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (01) : 105 - 120
  • [23] A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
    Hodgson, JG
    Agopyan, N
    Gutekunst, CA
    Leavitt, BR
    LePiane, F
    Singaraja, R
    Smith, DJ
    Bissada, N
    McCutcheon, K
    Nasir, J
    Jamot, L
    Li, XJ
    Stevens, ME
    Rosemond, E
    Roder, JC
    Phillips, AG
    Rubin, EM
    Hersch, SM
    Hayden, MR
    [J]. NEURON, 1999, 23 (01) : 181 - 192
  • [24] Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
    Kazantsev, A
    Preisinger, E
    Dranovsky, A
    Goldgaber, D
    Housman, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11404 - 11409
  • [25] Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
    Kistner, A
    Gossen, M
    Zimmermann, F
    Jerecic, J
    Ullmer, C
    Lubbert, H
    Bujard, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 10933 - 10938
  • [26] Ataxin-1 nuclear localization and aggregation:: Role in polyglutamine-induced disease in SCA1 transgenic mice
    Klement, IA
    Skinner, PJ
    Kaytor, MD
    Yi, H
    Hersch, SM
    Clark, HB
    Zoghbi, HY
    Orr, HT
    [J]. CELL, 1998, 95 (01) : 41 - 53
  • [27] The CAG/polyglutamine tract diseases: Gene products and molecular pathogenesis
    Koshy, BT
    Zoghbi, HY
    [J]. BRAIN PATHOLOGY, 1997, 7 (03) : 927 - 942
  • [28] Structural neurology: Are seeds at the root of neuronal degeneration?
    Lansbury, PT
    [J]. NEURON, 1997, 19 (06) : 1151 - 1154
  • [29] Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO
  • [30] 2-F